Tokio Marine Asset Management Co. Ltd. reduced its position in Clorox Co. (NYSE:CLX) by 0.6% during the second quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 11,734 shares of the company’s stock after selling 66 shares during the period. Tokio Marine Asset Management Co. Ltd.’s holdings in Clorox were worth $1,624,000 as of its most recent filing with the SEC.
Other institutional investors have also modified their holdings of the company. Legal & General Group Plc raised its stake in Clorox by 1.7% in the first quarter. Legal & General Group Plc now owns 682,421 shares of the company’s stock valued at $86,041,000 after buying an additional 11,428 shares during the last quarter. First Republic Investment Management Inc. raised its stake in Clorox by 5.7% in the first quarter. First Republic Investment Management Inc. now owns 200,233 shares of the company’s stock valued at $25,242,000 after buying an additional 10,868 shares during the last quarter. Shell Asset Management Co. raised its stake in Clorox by 9.6% in the second quarter. Shell Asset Management Co. now owns 103,486 shares of the company’s stock valued at $14,321,000 after buying an additional 9,034 shares during the last quarter. Boston Advisors LLC raised its stake in Clorox by 14.3% in the second quarter. Boston Advisors LLC now owns 196,360 shares of the company’s stock valued at $27,174,000 after buying an additional 24,501 shares during the last quarter. Finally, Confluence Investment Management LLC raised its stake in Clorox by 6.0% in the second quarter. Confluence Investment Management LLC now owns 83,966 shares of the company’s stock valued at $11,620,000 after buying an additional 4,777 shares during the last quarter. 70.27% of the stock is owned by institutional investors and hedge funds.
Clorox Co. (NYSE:CLX) traded up 0.42% on Friday, hitting $125.18. The stock had a trading volume of 827,177 shares. The company has a 50-day moving average of $127.93 and a 200 day moving average of $130.05. The company has a market cap of $16.21 billion, a PE ratio of 25.44 and a beta of 0.33. Clorox Co. has a 12 month low of $117.08 and a 12 month high of $140.47.
Clorox (NYSE:CLX) last announced its quarterly earnings data on Wednesday, August 3rd. The company reported $1.26 earnings per share (EPS) for the quarter, missing the consensus estimate of $1.28 by $0.02. Clorox had a return on equity of 296.91% and a net margin of 11.25%. The firm earned $1.60 billion during the quarter, compared to analysts’ expectations of $1.58 billion. During the same quarter in the previous year, the business earned $1.44 earnings per share. The company’s revenue for the quarter was up 2.8% compared to the same quarter last year. On average, analysts predict that Clorox Co. will post $5.49 EPS for the current fiscal year.
The company also recently disclosed a quarterly dividend, which will be paid on Monday, November 14th. Stockholders of record on Wednesday, October 26th will be paid a $0.80 dividend. This represents a $3.20 annualized dividend and a dividend yield of 2.56%. The ex-dividend date of this dividend is Monday, October 24th. Clorox’s payout ratio is 64.91%.
Several equities research analysts have recently commented on CLX shares. Atlantic Securities raised shares of Clorox from a “hold” rating to a “buy” rating and set a $144.00 price target for the company in a research report on Friday, September 16th. Deutsche Bank AG reiterated a “hold” rating and set a $134.00 price objective (up from $130.00) on shares of Clorox in a research note on Sunday, July 24th. Zacks Investment Research upgraded Clorox from a “hold” rating to a “buy” rating and set a $148.00 price objective for the company in a research note on Monday, August 8th. Goldman Sachs Group Inc. reiterated a “neutral” rating and set a $131.00 price objective (up from $125.00) on shares of Clorox in a research note on Friday, July 15th. Finally, Jefferies Group reiterated a “hold” rating on shares of Clorox in a research note on Wednesday, August 3rd. Two analysts have rated the stock with a sell rating, seven have issued a hold rating and two have issued a buy rating to the company’s stock. Clorox currently has a consensus rating of “Hold” and a consensus price target of $128.90.
In related news, SVP Jon M. Balousek sold 5,136 shares of Clorox stock in a transaction that occurred on Monday, August 29th. The stock was sold at an average price of $131.14, for a total transaction of $673,535.04. Following the completion of the transaction, the senior vice president now directly owns 15,384 shares in the company, valued at $2,017,457.76. The sale was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Also, COO Dawn C. Willoughby sold 10,617 shares of Clorox stock in a transaction that occurred on Wednesday, August 17th. The shares were sold at an average price of $131.01, for a total value of $1,390,933.17. Following the transaction, the chief operating officer now owns 20,353 shares of the company’s stock, valued at $2,666,446.53. The disclosure for this sale can be found here. 2.09% of the stock is owned by insiders.
Clorox Company Profile
The Clorox Company is a manufacturer and marketer of consumer and professional products. The Company sells its products primarily through mass retail outlets, e-commerce channels, wholesale distributors and medical supply distributors. The Company operates through four segments: Cleaning, Household, Lifestyle and International.
Want to see what other hedge funds are holding CLX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Clorox Co. (NYSE:CLX).
Receive News & Ratings for Clorox Co. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Clorox Co. and related companies with MarketBeat.com's FREE daily email newsletter.